ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 1994-01-01
- Employees
- 37
- Market Cap
- -
- Website
- https://www.ocata.com
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- Conditions
- Age-Related Macular Degeneration
- Interventions
- First Posted Date
- 2017-06-06
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Astellas Institute for Regenerative Medicine
- Target Recruit Count
- 42
- Registration Number
- NCT03178149
- Locations
- 🇺🇸
Retinal Consultants of Arizona LTD, Retinal Research Institute, Phoenix, Arizona, United States
🇺🇸Jules Stein Eye Institute, Los Angeles, California, United States
🇺🇸Stanford University Byers Eye Institute, Palo Alto, California, United States
A Safety Surveillance Study in Subjects With Macular Degenerative Disease Treated With Human Embryonic Stem Cell-derived Retinal Pigment Epithelial Cell Therapy
- Conditions
- Macular Degenerative Disease
- Interventions
- Biological: Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells
- First Posted Date
- 2017-05-25
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- Astellas Institute for Regenerative Medicine
- Target Recruit Count
- 36
- Registration Number
- NCT03167203
- Locations
- 🇬🇧
Site GB44001, London, United Kingdom
🇺🇸Private Practice, Kansas City, Missouri, United States
A Follow up Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)
- Conditions
- Stargardt's Macular Dystrophy
- Interventions
- Biological: hESC-RPE
- First Posted Date
- 2016-10-21
- Last Posted Date
- 2020-12-10
- Lead Sponsor
- Astellas Institute for Regenerative Medicine
- Target Recruit Count
- 12
- Registration Number
- NCT02941991
- Locations
- 🇬🇧
Moorefields Eye Hospital NHS Foundation Trust, London, United Kingdom
🇬🇧Newcastle on Tyne NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD
- Conditions
- Age-Related Macular Degeneration
- Interventions
- Biological: Sub-retinal transplantation of MA09-hRPE cellsProcedure: Sham Surgery
- First Posted Date
- 2015-09-30
- Last Posted Date
- 2017-07-26
- Lead Sponsor
- Astellas Institute for Regenerative Medicine
- Registration Number
- NCT02563782
- Locations
- 🇺🇸
Wills Eye Institute, Philadelphia, Pennsylvania, United States
Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD
- First Posted Date
- 2015-06-04
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Astellas Institute for Regenerative Medicine
- Target Recruit Count
- 11
- Registration Number
- NCT02463344
- Locations
- 🇺🇸
Mass Eye and Ear, Boston, Massachusetts, United States
🇺🇸Jules Stein Eye Institute, UCLA School of Medicine, Los Angeles, California, United States
🇺🇸Bascom Palmer Eye Institute, Miami, Florida, United States
Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients
- First Posted Date
- 2015-05-15
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Astellas Institute for Regenerative Medicine
- Target Recruit Count
- 13
- Registration Number
- NCT02445612
- Locations
- 🇺🇸
Wills Eye Institute-Mid Atlantic Retina, Philadelphia, Pennsylvania, United States
🇺🇸Jules Stein Eye Institute, UCLA School of Medicine, Los Angeles, California, United States
🇺🇸Bascom Palmer Eye Institute, Miami, Florida, United States
Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)
- First Posted Date
- 2011-11-10
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Astellas Institute for Regenerative Medicine
- Target Recruit Count
- 12
- Registration Number
- NCT01469832
- Locations
- 🇬🇧
Lothian Health Board Headquarters at Waverley Gate, Edinburgh, United Kingdom
🇬🇧Moorefields Eye Hospital NHS Foundation Trust, London, United Kingdom
🇬🇧Newcastle on Tyne NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration
- First Posted Date
- 2011-04-29
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Astellas Institute for Regenerative Medicine
- Target Recruit Count
- 13
- Registration Number
- NCT01344993
- Locations
- 🇺🇸
Bascom Palmer Eye Institute, Miami, Florida, United States
🇺🇸Jules Stein Eye Institute, UCLA School of Medicine, Los Angeles, California, United States
🇺🇸Mass Eye and Ear, Boston, Massachusetts, United States
Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular Dystrophy
- First Posted Date
- 2011-04-29
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Astellas Institute for Regenerative Medicine
- Target Recruit Count
- 13
- Registration Number
- NCT01345006
- Locations
- 🇺🇸
Bascom Palmer Eye institute, Miami, Florida, United States
🇺🇸Jules Stein Eye Institute, UCLA School of Medicine, Los Angeles, California, United States
🇺🇸Wills Eye Institute-Mid Atlantic Retina, Philadelphia, Pennsylvania, United States